Genmab A/S (FRA:GE91)

Genmab Revenue

Genmab had revenue of $1.02B USD in the quarter ending September 30, 2025, with 23.34% growth. This brings the company's revenue in the last twelve months to $3.85B, up 29.57% year-over-year. In the year 2024, Genmab had annual revenue of $2.99B with 22.32% growth.

• Revenue (ttm): $3.85B
• Revenue Growth: +29.57%
• P/S Ratio: 5.09
• Revenue / Employee: $1.43M
• Employees: 2,681
• Market Cap: 16.68B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.99B	545.24M	22.32%
Dec 31, 2023	2.44B	358.99M	17.23%
Dec 31, 2022	2.08B	796.62M	61.88%
Dec 31, 2021	1.29B	-374.23M	-22.52%
Dec 31, 2020	1.66B	855.79M	106.20%